2020
DOI: 10.1128/aac.01983-20
|View full text |Cite
|
Sign up to set email alerts
|

FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development

Abstract: The U.S. Food and Drug Administration (FDA) hosted a public workshop entitled “Advancing Animal Models for Antibacterial Drug Development” on March 5, 2020. The workshop mainly focused on models of pneumonia caused by Pseudomonas aeruginosa and Acinetobacter baumannii. The program included discussions from academic investigators, industry, and U.S. government scientists. The potential use of mouse, rabbit, and pig models for antibacterial drug development was presented and discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(18 citation statements)
references
References 6 publications
0
18
0
Order By: Relevance
“…The standard animal infection model is the mouse thigh infection model, which is relatively easy to handle. Given the move toward less clinical data and larger reliance on preclinical data, larger and more sophisticated animal models that better mimic the clinical picture in patients are being developed in rats, rabbits, and pigs 12 …”
Section: Preclinical Studies Of Antibioticsmentioning
confidence: 99%
“…The standard animal infection model is the mouse thigh infection model, which is relatively easy to handle. Given the move toward less clinical data and larger reliance on preclinical data, larger and more sophisticated animal models that better mimic the clinical picture in patients are being developed in rats, rabbits, and pigs 12 …”
Section: Preclinical Studies Of Antibioticsmentioning
confidence: 99%
“…However, organizations such as the Food and Drug Administration (FDA) have recently pushed for the continued advancement of in vitro and in vivo animal models for clinical studies that would not be plausible using in vivo animal models. These studies could gain information on the effects of drugs or processes that would be unethical to perform on humans and with the use of additional models provide greater confidence in results (Byrne et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Animal models for bacterial infection are often considered valuable tools for developing new drugs and vaccines ( Byrne et al 2020 ). Some mouse models of A. baumannii infection have been established, and immune responses and treatments against the pathogen have been analyzed ( Crandon et al 2009 ; Qiu et al 2009a ; 2009b ; Jacobs et al 2010 ).…”
Section: Introductionmentioning
confidence: 99%